- By insider
PRESIDENT AND CEO of Accelerate Diagnostics Inc (AXDX) Lawrence Mehren sold 400,068 shares of AXDX on 01/09/2017 at an average price of $19 a share. The total sale was $7.6 million.
Accelerate Diagnostics Inc is an in vitro diagnostics company. It is engaged in developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Accelerate Diagnostics Inc has a market cap of $1.22 billion; its shares were traded at around $23.20 with and P/S ratio of 7733.33.
-
Warning! GuruFocus has detected 2 Warning Signs with AXDX. Click here to check it out.
-
The intrinsic value of AXDX
CEO Recent Trades:
-
PRESIDENT AND CEO Lawrence Mehren sold 400,068 shares of AXDX stock on 01/09/2017 at the average price of $19. The price of the stock has increased by 22.11% since.
Directors and Officers Recent Trades:
-
Director, 10% Owner Jack W Schuler bought 339,368 shares of AXDX stock on 01/09/2017 at the average price of $19. The price of the stock has increased by 22.11% since.
-
Director, 10% Owner John Patience bought 52,700 shares of AXDX stock on 01/09/2017 at the average price of $19. The price of the stock has increased by 22.11% since.
-
Director Matthew Strobeck bought 8,000 shares of AXDX stock on 01/09/2017 at the average price of $19. The price of the stock has increased by 22.11% since.
For the complete insider trading history of AXDX, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 2 Warning Signs with AXDX. Click here to check it out.
-
The intrinsic value of AXDX